Chimeric clocks $4.17M R&D tax rebate from Canberra
Chimeric Therapeutics (ASX:CHM) has confirmed its receipt of a $4.17M tax rebate from Canberra for R&D activities.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
ATN | same boat as icg, size doesn't matter! | 21/10/13 | 14 | 2.6K | |||
|
|||||||
ATN | Ann: Correction Change of Name to Platypus Minera | 18/10/13 | 0 | 619 | |||
|
|||||||
ATN | Ann: Change of Company Name | 18/10/13 | 0 | 488 | |||
|
|||||||
ATN | Ann: Ceasing to be a substantial holder | 17/10/13 | 0 | 371 | |||
|
|||||||
ATN | Ann: Change in substantial holding | 17/10/13 | 0 | 389 | |||
|
|||||||
ATN | Ann: Initial Director's Interest Notice | 17/10/13 | 0 | 407 | |||
|
|||||||
ATN | Ann: Becoming a substantial holder | 16/10/13 | 0 | 203 | |||
|
|||||||
ATN | Ann: Initial Director's Interest Notice | 16/10/13 | 0 | 214 | |||
|
See All Discussions